Cystic fibrosis: New drug refused for Welsh NHS
Drugs that could transform the lives of some Cystic Fibrosis sufferers should not be available on the Welsh NHS, Welsh government advisers say.
Kalydeco is authorised in England, Scotland and Northern Ireland but it has not been recommended in Wales because of its cost.
Health Minister Mark Drakeford will now take the final decision on the drug.
Rhodri Lewis reports.